Revvity, Inc.

{
  "main_header": {
    "sid": 1159064,
    "name": "Revvity, Inc.",
    "stock_name": "Revvity, Inc.",
    "full_name": "Revvity, Inc.",
    "name_url": "stocks-analysis/revvity-inc",
    "exchange": 207,
    "exchangecode": "NYS",
    "primexch": 207,
    "country_id": 2,
    "currency": "USD",
    "cmp": "86.48",
    "chg": 0.91,
    "chgp": "1.06%",
    "dir": 1,
    "prev_price": "85.57",
    "mcapval": "9,668.41",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "US7140461093",
    "curr_date": "Mar 16",
    "curr_time": "",
    "bse_nse_vol": "688.74 k",
    "exc_status": "Active",
    "traded_date": "Mar 16, 2026",
    "traded_date_str": "2026 03 16",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/revvity-inc-1159064-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Revvity, Inc. Faces Valuation Shift Amid Declining Sales and Rising Costs",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/revvity-inc-stock-downgraded-to-sell-amid-declining-sales-and-high-valuation-3775247",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/RevvityInc_mojoScore_3775247.png",
        "date": "2025-12-30 15:36:32",
        "description": "Revvity, Inc., a small-cap company in the Pharmaceuticals & Biotechnology sector, has recently experienced a change in its valuation grade. Key financial metrics reveal challenges, including a decline in net sales and operating profit, alongside rising raw material costs and a high debt-equity ratio, impacting its market position."
      }
    ],
    "total": 20,
    "sid": "1159064",
    "stock_news_url": "https://www.marketsmojo.com/news/revvity-inc-1159064"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Revvity, Inc. Faces Valuation Shift Amid Declining Sales and Rising Costs

2025-12-30 15:36:32

Revvity, Inc., a small-cap company in the Pharmaceuticals & Biotechnology sector, has recently experienced a change in its valuation grade. Key financial metrics reveal challenges, including a decline in net sales and operating profit, alongside rising raw material costs and a high debt-equity ratio, impacting its market position.

Read full news article

View All News